Diffractive MIOLs provide better reading performance

Article

Post-op bilateral reading performance is significantly improved when using a multifocal intraocular lens (MIOL) with a diffractive component rather than a refractive multifocal or monofocal lens, according to a recent study.

Post-op bilateral reading performance is significantly improved when using a multifocal intraocular lens (MIOL) with a diffractive component rather than a refractive multifocal or monofocal lens, according to a recent study published in the Journal of Cataract & Refractive Surgery.

The study group, led by Dr Jorge Alió, Vissum-Instituto Oftalmológico de Alicante, Alicante, Spain, compared the bilateral reading performance within a 6-month follow up period after implantation with four different IOLs.

A total of 304 eyes of 152 patients underwent bilateral phacoemulsification and then implantation with one of four IOLs. The lenses used in the study were the Acri-Smart 48S monofocal, AcrySof Restor SN6AD3 apodized mutlifocal, Acri.LISA 366D diffractive multifocal and the ReZoom refractive mutlifocal. For comparison each patient’s bilateral reading performance was measured both with and without near correction and pre- and postoperatively with the Salzburg Reading Desk.

It was found that all groups demonstrated an improvement in uncorrected and corrected distance visual acuity after implantation of the IOLs. However, a significant improvement in uncorrected reading acuity was demonstrated in the groups that had been implanted with the apodized multifocal and diffractive multifocal lenses at 1 month and 6 months post-op. Additionally, the uncorrected reading speed of the study group was found to be much worse in patients implanted with the refractive multifocal lens in comparison with the monofocal lens implant at 1 month follow-up.

From the results it was concluded that MIOLs with a diffractive component offered the best option for post-op reading performance when compared with refractive multifocal and monofocal IOLs.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
At this year's Association for Research in Vision and Ophthalmology (ARVO) meeting in Salt Lake City, Utah, Nitish Mehta, MD, shared highlights from his research documenting real-world results of aflibercept 8 mg for patients with diabetic macular oedema.
ARVO 2025: Anat Loewenstein, MD, shares data from herself and her colleagues on meeting needs of patients with diabetic retinopathy
At the American Society of Cataract and Refractive Surgeons annual meeting, Sheng Lim, MD, FRCOphth discusses the benefit of endoscopic cyclophotocoagulation for patients with primary open angle glaucoma and cataracts in the CONCEPT study
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
© 2025 MJH Life Sciences

All rights reserved.